New treatment for severe asthma attacks in 50 years
Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of
Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.
Global representatives at a climate conference signed a $300 billion-a-year deal to finance emissions reductions — a move developing nations say falls way
HQ Team November 23, 2024: Dengue fever cases have almost doubled each year since 2021. This year saw more than 12.7 million cases in total
HQ Team November 23, 2024: A study has finally identified a previously unknown chemical, chloronitramide anion, lurking in drinking water across the United States,
HQ Team November 23, 2024: Social media has become a part of our social fabric. Research shows that people spend on an average
HQ Team November 22, 2024: Air pollution is a human carcinogenic and is associated with lung, breast and gastric cancers. Long-term exposure to
HQ Team November 22, 2024: Researchers at the University of California, San Diego, have developed a wearable ultrasound patch that continuously monitors blood
HQ Team November 20, 2024: A team of researchers from Kumamoto University has found that unique RNA structures known as G-quadruplexes (G4s) facilitate